Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective

Robles, Antonio; Gil-Rojas, Yaneth; Amaya, Devi; Hernández, Fabián; Escobar-Córdoba, Franklin; Venegas, Marco; Amado, Steve; Restrepo, S.M.; Echeverry, Jorge; Marín, Fernando; Zabala, Sandra; Bazurto-Zapata, María Angélica; Deger, M.

doi:10.1080/14737167.2023.2181792

Cited by 1 publication

(5 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One retrospective case-crossover [ 64 ] and one cohort study [ 63 ] ran economic evaluations concurrently. Twenty-five studies were model based, 14 using a Markov model [ 53 , 56 , 65 , 67 – 71 , 73 , 75 , 77 , 78 , 80 , 98 ], five using a decision-tree model [ 74 , 104 – 107 ], one using both Markov and decision-tree models [ 76 ], one using a semi-Markov model [ 79 ] and one using a decision analytic model [ 81 ]. Additionally, two studies used randomised controlled trial-based modelling [ 94 , 108 ], and one used a case-control-based model [ 72 ].…”

Section: Resultsmentioning

confidence: 99%

“…Japan [ 76 , 92 , 104 , 105 ] and Canada [ 68 , 77 , 80 , 101 ] each had four studies, The Netherlands had three studies [ 59 , 95 , 99 ], and Germany [ 96 , 102 ] and France [ 69 , 85 ] had two studies each. Single studies were conducted in Colombia [ 67 ], New Zealand [ 107 ], South Korea [ 103 ], Finland [ 63 ], Australia [ 84 ] and Hong Kong [ 91 ]. Most studies ( n = 28) were conducted in clinical settings, 25 in community settings, and one in a workplace environment.…”

Section: Resultsmentioning

confidence: 99%

“…The economic evaluations’ time horizons ranged from 1 day [ 81 ] to a lifetime [ 65 ]. Studies were published between 2003 [ 56 ] and 2023 [ 67 ], as shown in Table 1 .…”

Section: Resultsmentioning

confidence: 99%

“…Of the 57 studies included (Table 1 ), 32 had one type of QoL apiece: 27 generic [ 53 , 56 , 59 , 63 – 65 , 67 – 69 , 71 , 72 , 74 – 77 , 79 – 81 , 93 , 94 , 97 , 98 , 103 – 105 , 108 , 110 ], four sleep specific [ 84 , 87 , 96 , 101 ], and one depression specific [ 92 ]). Thirteen studies used a combination of one generic and one sleep-specific instrument [ 35 , 54 , 55 , 57 , 58 , 82 , 83 , 85 , 88 , 90 , 95 , 99 , 102 ], nine used two generic instruments each [ 60 – 62 , 66 , 70 , 73 , 78 , 106 , 107 ], two had two sleep-specific instruments [ 89 , 91 ], one utilised one generic and one depression-specific instrument [ 110 ], and one used a combination of a generic, a sleep-specific and osteoarthritis-specific tool [ 100 ].…”

Section: Resultsmentioning

confidence: 99%

“…The economic evaluations' time horizons ranged from 1 day [81] to a lifetime [65]. Studies were published between 2003 [56] and 2023 [67], as shown in Table 1. CUA, CEA EQ-5D-3L, HSDQ [89,91], one utilised one generic and one depression-specific instrument [110], and one used a combination of a generic, a sleep-specific and osteoarthritisspecific tool [100].…”

Section: Geographical Location Setting and Timeframementioning

confidence: 99%

See 4 more Smart Citations

Content Comparison of Quality-of-Life Instruments Used in Economic Evaluations of Sleep Disorder Interventions: A Systematic Review

Kaambwa,

Woods,

Natsky

et al. 2024

PharmacoEconomics

View full text Add to dashboard Cite

Background Assessment of quality of life (QoL) in people living with sleep disorders using questionnaires is necessary to compare intervention benefits. Knowledge of the content and concepts covered by specific QoL instruments is essential to determine which instruments are best suited for conducting economic evaluations of sleep-related interventions. Objectives This review aims to identify the QoL instruments that have been applied in economic evaluations of sleep disorder interventions and compare their conceptual overlap and content coverage using the framework of the International Classification of Functioning, Disability and Health (ICF). Methods A systematic review of full economic evaluations in sleep published in peer-reviewed journals from conception to 30 May, 2023 was conducted. MEDLINE, PsychInfo, ProQuest, Cochrane, Scopus, CINAHL, Web of Science and Emcare were searched for eligible studies. Studies incorporating either generic or sleep-specific QoL instruments as the primary or secondary measures of effectiveness within a full economic evaluation were included. Quality appraisal against the JBI Critical Appraisal Checklist for Economic Evaluations and EURONHEED checklists and mapping of QoL items to ICF categories were performed by two reviewers, with a third helping settle any potential differences. Results Sixteen instruments were identified as having been used in sleep health economic evaluations. The EQ-5D-3L, Epworth Sleepiness Scale, and Insomnia Severity Index were the most widely used, but the latter two are predominantly diagnostic tools and not specifically designed to guide economic evaluations. Other instruments with broader ICF content coverage have been least used, and these include the Sleep Apnea Quality of Life Index, Functional Outcomes of Sleep Questionnaire, 15 Dimensions, Short-Form 6 Dimensions, 12-item Short Form Survey, 36-item Short Form Survey and the GRID Hamilton Rating Scale for Depression. Conclusions This study provides an overview of current QoL instruments used in economic evaluations of sleep with respect to their content coverage. A combination of generic and sleep-specific instruments with broader ICF content coverage is recommended for such evaluations. Supplementary Information The online version contains supplementary material available at 10.1007/s40273-023-01349-5.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…The economic evaluations’ time horizons ranged from 1 day [ 81 ] to a lifetime [ 65 ]. Studies were published between 2003 [ 56 ] and 2023 [ 67 ], as shown in Table 1 .…”

Section: Resultsmentioning

confidence: 99%